CGEM · Cullinan Therapeutics, Inc.
AI read · Good for CGEM
The AI's read
This gives Cullinan an encouraging sign that its lupus treatment may help the kidneys. The study is still early and ongoing, so more testing must confirm the result.
Cullinan reported 4 complete kidney responses, an encouraging sign for its lupus treatment. The study is still early and ongoing, so more testing must confirm the result.
This gives Cullinan an encouraging sign that its lupus treatment may help the kidneys. The study is still early and ongoing, so more testing must confirm the result.
Follow Cullinan Therapeutics, Inc. (CGEM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CGEM